Diseases, Conditions, Syndromes

How safe are the new COVID-19 vaccines?

(HealthDay)—Two COVID-19 vaccines are on the verge of approval in the United States, with pharmaceutical companies promising that millions of doses will be available to the first wave of recipients within a matter of weeks.

Medical research

COVID vaccine development was quick. What's holding HIV back?

While multiple effective COVID-19 vaccines were developed with astonishing speed, it has been more than 40 years since University of Rochester alumnus Michael Gottlieb, M.D., first described the disease that became known ...

Genetics

Approach that new gene testing kit with caution

(HealthDay)—Lots of Americans will unwrap a scarf or sweater this holiday season. But a growing number will receive a gift that's potentially life-changing: an at-home genetic testing kit.

Gerontology & Geriatrics

Report identifies three dimensions to lifelong 'longevity fitness'

Perseverance and attention to social connections, health, and finances will give people the best chance to thrive as they age, according to a new report titled "Longevity Fitness: Financial and Health Dimensions Across the ...

Diseases, Conditions, Syndromes

COPD underdiagnosed in older adults, but can be managed

"Recognizing and Treating COPD in Older Adults," the latest issue of the What's Hot newsletter from The Gerontological Society of America, addresses what is known about the prevalence, incidence, and impact of chronic obstructive ...

Medications

New ALS drug approved in Canada while still under FDA review

An experimental drug for the neurological disorder ALS was approved in Canada on Monday, but an ongoing evaluation of the treatment by the U.S. Food and Drug Administration has raised questions about its effectiveness.

page 1 from 3